These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37796613)

  • 21. Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations.
    Zhang Y; Tanabe N; Shima H; Shiraisi Y; Oguma T; Sato A; Muro S; Sato S; Hirai T
    COPD; 2022; 19(1):149-157. PubMed ID: 35392737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of exacerbations of asthma and COPD during one year in primary care.
    Al-ani S; Spigt M; Hofset P; Melbye H
    Fam Pract; 2013 Dec; 30(6):621-8. PubMed ID: 24115012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of CAPTURE to Identify Individuals Who May or May Not Require Treatment for Chronic Obstructive Pulmonary Disease.
    Li Y; Wen F; Ma Q; Chen R; Sun Y; Liu T; Gu C; Hu S; Song J; Compton C; Zheng J; Zhong N; Jones P
    Am J Respir Crit Care Med; 2023 Aug; 208(4):435-441. PubMed ID: 37315325
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study.
    Corhay JL; Vincken W; Schlesser M; Bossuyt P; Imschoot J
    Int J Clin Pract; 2013 Dec; 67(12):1294-301. PubMed ID: 24246208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.
    So JY; Zhao H; Voelker H; Reed RM; Sin D; Marchetti N; Criner GJ
    Ann Am Thorac Soc; 2018 Nov; 15(11):1296-1303. PubMed ID: 30063372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
    Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
    Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease.
    Ingebrigtsen TS; Marott JL; Vestbo J; Nordestgaard BG; Hallas J; Lange P
    Respirology; 2015 Jan; 20(1):101-7. PubMed ID: 25297724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.
    Maselli DJ; Yen A; Wang W; Okajima Y; Dolliver WR; Mercugliano C; Anzueto A; Restrepo MI; Aksamit TR; Basavaraj A; Aliberti S; Young KA; Kinney GL; Wells JM; San José Estépar R; Lynch DA; Diaz AA
    Radiology; 2021 Sep; 300(3):706-714. PubMed ID: 34156303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
    Rothnie KJ; Numbere B; Gelwicks S; Lu Y; Sharma R; Compton C; Ismaila AS; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2673-2685. PubMed ID: 38022832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations.
    Ryu MH; Yun JH; Morrow JD; Saferali A; Castaldi P; Chase R; Stav M; Xu Z; Barjaktarevic I; Han M; Labaki W; Huang YJ; Christenson S; O'Neal W; Bowler R; Sin DD; Freeman CM; Curtis JL; Hersh CP
    Am J Respir Crit Care Med; 2023 Aug; 208(3):247-255. PubMed ID: 37286295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.